The Declotting Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of declotting devices has significantly increased in the past years. It is expected to rise from $2.13 billion in 2024 to $2.28 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%.
The Declotting Devices market is predicted to reach $2.92 billion in 2029, with a compound annual growth rate (CAGR) of 6.4%.
Download Your Free Sample of the 2025 Declotting Devices Market Report and Uncover Key Trends Now!The drivers in the declotting devices market are:
• Increasing regulatory approvals and support
• Rising trend of telemedicine
• Enhanced focus on remote monitoring
• Expansion of healthcare facilities and emphasis on patient safety regulations
The declotting devices market covered in this report is segmented –
1) By Product: Mechanical Declotting Device, Embolectomy Balloon
2) By Thrombectomy Device: Aspiration Thrombectomy Devices, Percutaneous Mechanical Thrombectomy Devices, Other Thrombectomy Devices
3) By End Use: Hospitals, Clinics, Other End Uses
The trends in the declotting devices market are:
• Innovation in anticoagulant therapy is one emerging trend in the declotting devices market.
• Collaboration with technology companies is significantly shaping the market.
• There is a growing trend toward the customization of declotting devices.
• The expanding applications of declotting devices are a notable emerging trend within the sector.
The major players in the declotting devices market are:
• Johnson & Johnson
• Abbott Laboratories
• Medtronic Ltd
• Koninklijke Philips NV
• Stryker Corporation
• Baxter International Inc
• Boston Scienti
North America was the largest region in the declotting devices market in 2024